Stock Market

Sun Pharma declines over 4% on unexpected Q2 loss

   Download Android App    Share in      FullScreen   CheckVideos

NEW DELHI: Shares of Sun Pharma dipped over 4 per cent in early trade on Wednesday after the pharma major posted a consolidated loss of Rs 218.82 crore for the quarter ended September 30, on a one-time loss of Rs 1,214.38 crore with respect to Modafinil antitrust litigation. The scrip was trading 4.31 per cent down at Rs 537.50 at around 10.00 am (IST), while the benchmark BSE Sensex was down 0.19 per cent at 35,078.18.

The consolidated total revenue for the company increased 4.32 per cent year-on-year to Rs 6,937.63 crore during the quarter under review against Rs 6,650.34 crore in the same period last year.

Ebitda rose to Rs 1,530.90 crore during the September quarter against Rs 376 crore last year.

Meanwhile, the shares of Sun Pharma opened at Rs 558.50 on BSE against its previous close of Rs 561.70.




Unlimited Portal Access + Monthly Magazine - 12 issues-Publication from Jan 2021

Buy Our Merchandise (Peace Series)

 

Contribute US to Start Broadcasting


It's Voluntary! Take care of your Family, Friends and People around You First and later think about us. Its Fine if you dont wish to contribute and if you wish to contribute then think about the Homeless first and Feed them. We can survive with your wishes too :-). You can Buy our Merchandise too which are of the finest quality.

Debit/Credit/UPI

UPI/Debit/Credit

Paytm

STRIPE

Details
Category: Stock Market


21